Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF AFRICA BIOANALYTICAL TESTING SERVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER'S FIVE FORCES
4.2 PESTEL ANALYSIS
5 AFRICA BIOANALYTICAL TESTING SERVICES MARKET: REGULATIONS
5.1 REGULATION IN AFRICA:
5.1.1 GUIDELINES FOR BIOANALYTICAL TESTING SERVICES BY SAHPRA:
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISE IN FOCUS ON THE ANALYTICAL TESTING OF BIOLOGICS AND BIOSMILARS
6.1.2 INCREASE IN PREFERENCE FOR OUTSOURCING ANALYTICAL TESTING
6.1.3 GROWING R&D EXPENDITURE IN THE PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY
6.2 RESTRAINTS
6.2.1 DEARTH OF SKILLED PROFESSIONALS
6.2.2 PRICING PRESSURE FACED BY MAJOR PLAYERS
6.3 OPPORTUNITIES
6.3.1 RISE IN ADOPTION OF THE QUALITY BY DESIGN APPROACH
6.3.2 RISE IN DEMAND FOR SPECIALIZED BIOANALYTICAL TESTING SERVICES
6.3.3 STRATEGIC INITIATIVES OF KEY PLAYERS
6.4 CHALLENGES
6.4.1 INNOVATIVE FORMULATIONS DEMANDING A UNIQUE BIOANALYTICAL TESTING APPROACH
6.4.2 GROWING NEED TO IMPROVE THE SENSITIVITY OF BIOANALYTICAL METHODS
7 AFRICA BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE
7.1 OVERVIEW
7.2 BIOANALYTICAL SERVICES FOR PRECLINICAL AND CLINICAL STUDIES
7.2.1 PHARMACOKINETIC (PK) ANALYSIS
7.2.2 BIOEQUIVALENCE STUDIES
7.2.3 BIOAVAILABILITY STUDIES
7.2.4 METHOD DEVELOPMENT & VALIDATION
7.2.5 LEAD OPTIMIZATION STUDIES
7.2.6 DOSE FORMULATION ANALYSIS
7.2.7 BIOANALYTICAL TECHNOLOGIES
7.2.8 OTHERS
7.3 SMALL MOLECULE BIOANALYTICAL SERVICES
7.3.1 METHOD DEVELOPMENT & VALIDATION
7.3.2 METABOLITE IDENTIFYING & SCREENING
7.3.3 SUPPORT FOR PRE-CLINICAL ANIMAL STUDIES
7.3.4 DRIED BLOOD SPOT ANALYSIS
7.3.5 TISSUE BIOANALYSIS
7.3.6 HAZARDOUS SAMPLE LABORATORY FOR HIV & HEPATITIS-B
7.3.7 BIOMARKERS ASSAY
7.3.8 OTHERS
7.4 LARGE MOLECULE BIOANALYTICAL SERVICES
7.4.1 IMMUNOCHEMISTRY SERVICES
7.4.2 BIOMARKER ASSAYS
7.4.3 METABOLITE IDENTIFYING & SCREENING
7.4.4 QUANTITATIVE IMMUNOASSAYS
7.4.5 IMMUNOGENICITY ASSAYS
7.4.6 PHARMACOKINETICS (PK) ANALYSIS
7.4.7 LIGAND-BINDING ASSAYS
7.4.8 OTHERS
8 AFRICA BIOANALYTICAL TESTING SERVICES MARKET, BY END USER
8.1 OVERVIEW
8.2 CLINICAL RESEARCH ORGANIZATIONS
8.3 ACADEMIC AND RESEARCH INSTITUTES
8.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
8.5 HOSPITALS LABS
8.6 OTHERS
9 AFRICA BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY
9.1 SOUTH AFRICA
9.2 NIGERIA
9.3 ETHIOPIA
9.4 ANGOLA
9.5 REST OF AFRICA
10 AFRICA BIOANALYTICAL TESTING SERVICES MARKET: COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: AFRICA
11 SWOT ANALYSIS
12 COMPANY PROFILE
12.1 LABCORP
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUE ANALYSIS
12.1.3 PRODUCT PORTFOLIO
12.1.4 RECENT DEVELOPMENTS
12.2 FARMOVS (PTY) LTD
12.2.1 COMPANY SNAPSHOT
12.2.2 PRODUCT PORTFOLIO
12.2.3 RECENT DEVELOPMENTS
12.3 SGS SA
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 PRODUCT PORTFOLIO
12.3.4 RECENT DEVELOPMENTS
12.4 BARC SOUTH AFRICA
12.4.1 COMPANY SNAPSHOT
12.4.2 PRODUCT PORTFOLIO
12.4.3 RECENT DEVELOPMENTS
12.5 Q2 SOLUTIONS.
12.5.1 COMPANY SNAPSHOT
12.5.2 PRODUCT PORTFOLIO
12.5.3 RECENT DEVELOPMENTS
12.6 MEDPACE
12.6.1 COMPANY SNAPSHOT
12.6.2 REVENUE ANALYSIS
12.6.3 PRODUCT PORTFOLIO
12.6.4 RECENT DEVELOPMENTS
12.7 MERIEUX NUTRISCIENCES CORPORATION
12.7.1 COMPANY SNAPSHOT
12.7.2 PRODUCT PORTFOLIO
12.7.3 RECENT DEVELOPMENTS
12.8 SYNEXA LIFE SCIENCES BV
12.8.1 COMPANY SNAPSHOT
12.8.2 PRODUCT PORTFOLIO
12.8.3 RECENT DEVELOPMENTS
13 QUESTIONNAIRE
14 RELATED REPORTS
List of Table
TABLE 1 AFRICA BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 2 AFRICA BIOANALYTICAL SERVICES FOR PRECLINICAL AND CLINICAL STUDIES IN BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 3 AFRICA SMALL MOLECULE BIOANALYTICAL SERVICES IN BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 4 AFRICA LARGE MOLECULE BIOANALYTICAL SERVICES IN BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 5 AFRICA BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 6 AFRICA BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2020-2029 (USD THOUSAND )
TABLE 7 SOUTH AFRICA BIOANALYTICAL TESTING SERVICES MARKETS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 8 SOUTH AFRICA BIOANALYTICAL SERVICES FOR PRECLINICAL AND CLINICAL STUDIES IN BIOANALYTICAL TESTING SERVICES MARKETS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 9 SOUTH AFRICA SMALL MOLECULE BIOANALYTICAL SERVICES IN BIOANALYTICAL TESTING SERVICES MARKETS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 10 SOUTH AFRICA LARGE MOLECULE BIOANALYTICAL SERVICES IN BIOANALYTICAL TESTING SERVICES MARKETS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 11 SOUTH AFRICA BIOANALYTICAL TESTING SERVICES MARKETS MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 12 NIGERIA BIOANALYTICAL TESTING SERVICES MARKETS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 13 NIGERIA BIOANALYTICAL SERVICES FOR PRECLINICAL AND CLINICAL STUDIES IN BIOANALYTICAL TESTING SERVICES MARKETS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 14 NIGERIA SMALL MOLECULE BIOANALYTICAL SERVICES IN BIOANALYTICAL TESTING SERVICES MARKETS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 15 NIGERIA LARGE MOLECULE BIOANALYTICAL SERVICES IN BIOANALYTICAL TESTING SERVICES MARKETS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 16 NIGERIA BIOANALYTICAL TESTING SERVICES MARKETS MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 17 ETHIOPIA BIOANALYTICAL TESTING SERVICES MARKETS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 18 ETHIOPIA BIOANALYTICAL SERVICES FOR PRECLINICAL AND CLINICAL STUDIES IN BIOANALYTICAL TESTING SERVICES MARKETS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 19 ETHIOPIA SMALL MOLECULE BIOANALYTICAL SERVICES IN BIOANALYTICAL TESTING SERVICES MARKETS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 20 ETHIOPIA LARGE MOLECULE BIOANALYTICAL SERVICES IN BIOANALYTICAL TESTING SERVICES MARKETS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 21 ETHIOPIA BIOANALYTICAL TESTING SERVICES MARKETS MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 22 ANGOLA BIOANALYTICAL TESTING SERVICES MARKETS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 23 ANGOLA BIOANALYTICAL SERVICES FOR PRECLINICAL AND CLINICAL STUDIES IN BIOANALYTICAL TESTING SERVICES MARKETS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 24 ANGOLA SMALL MOLECULE BIOANALYTICAL SERVICES IN BIOANALYTICAL TESTING SERVICES MARKETS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 25 ANGOLA LARGE MOLECULE BIOANALYTICAL SERVICES IN BIOANALYTICAL TESTING SERVICES MARKETS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 26 ANGOLA BIOANALYTICAL TESTING SERVICES MARKETS MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 27 REST OF AFRICA BIOANALYTICAL TESTING SERVICES MARKETS MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
List of Figure
FIGURE 1 AFRICA BIOANALYTICAL TESTING SERVICESMARKET: SEGMENTATION
FIGURE 2 AFRICA BIOANALYTICAL TESTING SERVICES MARKET: DATA TRIANGULATION
FIGURE 3 AFRICA BIOANALYTICAL TESTING SERVICES MARKET: DROC ANALYSIS
FIGURE 4 AFRICA BIOANALYTICAL TESTING SERVICES MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 AFRICA BIOANALYTICAL TESTING SERVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 AFRICA BIOANALYTICAL TESTING SERVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 AFRICA BIOANALYTICAL TESTING SERVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 AFRICA BIOANALYTICAL TESTING SERVICES MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 AFRICA BIOANALYTICAL TESTING SERVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 AFRICA BIOANALYTICAL TESTING SERVICES MARKET: SEGMENTATION
FIGURE 11 THE RISING FOCUS ON THE ANALYTICAL TESTING OF BIOLOGICS AND BIOSIMILARS AND RISE IN DEMAND FOR SPECIALIZED BIOANALYTICAL TESTING SERVICES ARE EXPECTED TO DRIVE THE AFRICA BIOANALYTICAL TESTING SERVICES MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 BIOANALYTICAL SERVICES FOR PRECLINICAL AND CLINICAL STUDIES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE AFRICA BIOANALYTICAL TESTING SERVICES MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE AFRICA BIOANALYTICAL TESTING SERVICES MARKET
FIGURE 14 AFRICA BIOANALYTICAL TESTING SERVICES MARKET: BY TYPE, 2021
FIGURE 15 AFRICA BIOANALYTICAL TESTING SERVICES MARKET: BY TYPE, 2022-2029 (USD THOUSAND)
FIGURE 16 AFRICA BIOANALYTICAL TESTING SERVICES MARKET: BY TYPE, CAGR (2022-2029)
FIGURE 17 AFRICA BIOANALYTICAL TESTING SERVICES MARKET: BY TYPE, LIFELINE CURVE
FIGURE 18 AFRICA BIOANALYTICAL TESTING SERVICES MARKET: BY END USER, 2021
FIGURE 19 AFRICA BIOANALYTICAL TESTING SERVICES MARKET: BY END USER, 2022-2029 (USD THOUSAND)
FIGURE 20 AFRICA BIOANALYTICAL TESTING SERVICES MARKET: BY END USER, CAGR (2022-2029)
FIGURE 21 AFRICA BIOANALYTICAL TESTING SERVICES MARKET: BY END USER, LIFELINE CURVE
FIGURE 22 AFRICA BIOANALYTICAL TESTING SERVICES MARKET: SNAPSHOT (2021)
FIGURE 23 AFRICA BIOANALYTICAL TESTING SERVICES MARKET: BY COUNTRY (2021)
FIGURE 24 AFRICA BIOANALYTICAL TESTING SERVICES MARKET: BY COUNTRY (2022 & 2029)
FIGURE 25 AFRICA BIOANALYTICAL TESTING SERVICES MARKET: BY COUNTRY (2021 & 2029)
FIGURE 26 AFRICA BIOANALYTICAL TESTING SERVICES MARKET: BY TYPE (2022-2029)
FIGURE 27 AFRICA BIOANALYTICAL TESTING SERVICES MARKET: COMPANY SHARE 2021 (%)
